References
- Molinari F, Frattini M. KRAS mutational test for metastatic colorectal cancer patients: not just a technical problem. Expert Rev. Mol. Diagn.12(2), 123–126 (2012).
- Hamfjord J, Stangeland AM, Skrede ML, Tveit KM, Ikdahl T, Kure EH. Wobble enhanced ARMS (WE-ARMS) method for detecting KRAS and BRAF mutations in patients with advanced colorectal cancer. Diagn. Mol. Pathol.20(3), 158–165 (2011).
- Tveit KM, Guren T, Glimelius B et al. Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study. J. Clin. Oncol. (2012) (In Press).